Your browser doesn't support javascript.
loading
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.
Quint, Jennifer K; Arnetorp, Sofie; Kocks, Janwillem W H; Kupczyk, Maciej; Nuevo, Javier; Plaza, Vicente; Cabrera, Claudia; Raherison-Semjen, Chantal; Walker, Brandie; Penz, Erika; Gilbert, Ileen; Lugogo, Njira Lucia; van der Valk, Ralf J P.
Afiliação
  • Quint JK; Faculty of Medicine, National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: j.quint@imperial.ac.uk.
  • Arnetorp S; Payer Analytics, AstraZeneca, Gothenburg, Sweden.
  • Kocks JWH; General Practitioners Research Institute, Groningen, The Netherlands; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Observational and Pragmatic Research Institute, Singapore; Groningen Research Institute Asthma and COPD (GRIAC),
  • Kupczyk M; Department of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland; Center for Allergy Research, IMM, Karolinska Institutet, Stockholm, Sweden.
  • Nuevo J; Evidence Generation, AstraZeneca, Madrid, Spain.
  • Plaza V; Executive Committee of GEMA, Spanish Society of Pulmonology and Thoracic Surgery (SEPAR); Pneumology and Allergy Service, Hospital Santa Creu i Sant, Barcelona, Spain.
  • Cabrera C; BioPharmaceuticals Medical (Evidence), AstraZeneca, Gothenburg, Sweden.
  • Raherison-Semjen C; Department of Pulmonary Medicine, CHU Bordeaux, INSERM U1219 Bordeaux University, Bordeaux, France.
  • Walker B; Department of Medicine, Division of Respirology, University of Calgary, Calgary, Alta, Canada.
  • Penz E; Department of Medicine, Division of Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, Sask, Canada; Respiratory Research Center, University of Saskatchewan, Saskatoon, Sask, Canada.
  • Gilbert I; Medical Affairs, AstraZeneca, Wilmington, Del.
  • Lugogo NL; Department of Pulmonary & Critical Care Medicine, University of Michigan, Ann Arbor, Mich.
  • van der Valk RJP; Medical Affairs, AstraZeneca, Cambridge, United Kingdom.
J Allergy Clin Immunol Pract ; 10(9): 2297-2309.e10, 2022 09.
Article em En | MEDLINE | ID: mdl-35364341
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Aged / Humans Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies Limite: Aged / Humans Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2022 Tipo de documento: Article